Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Osteomalacia is a mineralization defect, usually from vitamin D deficiency, phosphate wasting, or malabsorption, so bisphosphonates cannot repair it and instead suppress the bone turnover needed to lay down healthy mineral, leaving soft osteoid, worsening bone pain, and raising the risk of hypocalcemia and atypical or insufficiency fractures. Because low DXA scores look identical to osteoporosis, the misdiagnosis is common, and the crucial next steps involve checking 25-hydroxyvitamin D, calcium, phosphate, alkaline phosphatase, and PTH before any antiresorptive is started or continued. There are several important factors and lab patterns to consider, including when treatment can be safely resumed after repletion, so see below to understand more. Since bone pain, muscle weakness, waddling gait, and fractures overlap across many conditions, mapping your specific symptoms is the fastest way to know which testing conversation to have. Take a free, instant, online symptom check to better understand what may be driving your symptoms and to navigate your next steps with more confidence.
Last reviewed for medical accuracy: 08/18/2026
Why Treating Osteomalacia with Bisphosphonates Worsens Bone: Crucial Next Steps
In postmenopausal women, osteomalacia is often misdiagnosed as osteoporosis. While both conditions cause bone pain, muscle weakness and low bone density, their underlying problems and treatments differ sharply. Bisphosphonates—standard therapy for osteoporosis—can make osteomalacia worse by blocking the very bone-remodeling process that osteomalacia needs to heal. Recognizing and correcting this error is essential to restore bone strength and reduce fracture risk.
What Is Postmenopausal Osteomalacia Misdiagnosed as Osteoporosis?
Osteomalacia means “soft bones.” It results from defective bone mineralization, most often due to vitamin D deficiency or problems handling calcium and phosphate. Osteoporosis, in contrast, is a loss of bone mass and microarchitectural deterioration, leading to fragile bones. In postmenopausal women, both conditions can present with:
Because DEXA can’t distinguish soft, under-mineralized bone (osteomalacia) from genuinely brittle bone (osteoporosis), many women with osteomalacia are put on bisphosphonates by mistake.
Why Bisphosphonates Make Osteomalacia Worse
Bisphosphonates (alendronate, risedronate, zoledronic acid) work by shutting down osteoclasts, the cells that break down old bone. In osteoporosis, this slows bone loss and allows formation to outpace resorption. But in osteomalacia, the bone matrix (osteoid) remains unmineralized because of a shortage of calcium, phosphate or active vitamin D:
Key Studies and Guidelines
Clinical Red Flags for Misdiagnosis
Consider osteomalacia when a postmenopausal patient on bisphosphonates reports:
Crucial Diagnostic Steps
Detailed history and exam
Laboratory evaluation
Imaging
Bone biopsy (rarely needed)
Correcting the Misdiagnosis: Treatment Principles
Once osteomalacia is confirmed, bisphosphonates should be stopped. Focus shifts to restoring normal mineralization:
Vitamin D Repletion
Calcium and Phosphate Management
Address Underlying Causes
Monitor Response
Referral to Specialists
Patient Support and Self-Assessment
Living with osteomalacia can be challenging, but the right treatment leads to significant pain relief and stronger bones. If you’re experiencing persistent bone pain, muscle weakness or new fractures despite treatment, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a convenient way to track symptoms and gather information before your next medical visit.
When to Seek Immediate Help
Always contact a healthcare professional if you experience:
Speak to a doctor about any life-threatening or serious concerns. Early and accurate diagnosis is the key to reversing osteomalacia and avoiding the harm of inappropriate treatments like bisphosphonates.
Take-Home Messages
(References)
* Ziegler R. [Osteoporosis]. Schweiz Rundsch Med Prax. 1994 Sep 20;83(38):1051-5. PMID: 7939067.
* D'Erasmo E, Ragno A, Raejntroph N, Pisani D. [Drug-induced osteomalacia]. Recenti Prog Med. 1998 Oct;89(10):529-33. PMID: 9842257.
* Sato K. [Drug-induced osteomalacia]. Clin Calcium. 2007 Oct;17(10):1536-42. PMID: 17906405.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol. 2010 Apr-Jun;31(2):82-6. PMID: 20862980.
* Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):585-91. doi: 10.1016/j.beem.2011.05.002. PMID: 21872800.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Laurent MR, Harvengt P, Mortier GR, Böckenhauer D. X-Linked Hypophosphatemia. 1993. PMID: 22319799.
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Lewiecki EM. Osteoporosis: Clinical Evaluation. 2000. PMID: 25905277.
* Bhadada SK, Dhaliwal R, Dhiman V, Rao SD. Fibrogenesis Imperfecta Ossium. Calcif Tissue Int. 2019 May;104(5):561-569. doi: 10.1007/s00223-019-00547-8. 2019 May 8. PMID: 31069441.
* Watts NB, Chesnut CH 3rd, Genant HK, Harris ST, Jackson RD, Licata AA, Miller PD, Mysiw WJ, Richmond B, Valent D. History of etidronate. Bone. 2020 May;134:115222. doi: 10.1016/j.bone.2020.115222. 2020 Jan 3. PMID: 31911206.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.